Cancer Research & AI Health Initiative Gets Boost
Duke’s Cancer Research and AI Health Initiative Gets Boost $200,000 Grant from NCBiotech
by Elizabeth Witherspoon, PhD, NCBiotech Writer, via WRAL Techwire
Duke University researchers are using a grant from the North Carolina Biotechnology Center to “supercharge” vital medical information.
The Duke scientists say the instrumentation grant from NCBiotech enables them to use cutting-edge digital imaging and artificial intelligence (AI) technologies to advance cancer research, diagnostics and to support a vast new interdisciplinary data science initiative called AI Health.
NCBiotech’s $200,000 grant went to the Duke BioRepository & Precision Pathology Center (BRPC), Duke’s largest human tissue biobank. BRPC stores samples from consented patients for use in research.
Specifically, the March 2018 funding enabled BRPC to purchase of a Leica Aperio AT2 Digital Pathology Scanner. This state-of-the-art instrument performs high-throughput whole-slide imaging of both surgical pathology tissue slides and fluid sample preparations called cytopathology slides.
Circle photo (top): Shannon McCall, director, Duke BioRepository & Precision Pathology Center, and PI of the NCBiotech grant